Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Bausch Health Companies Inc. Common Stock
(NY:
BHC
)
4.590
-0.110 (-2.34%)
Official Closing Price
Updated: 7:00 PM EDT, May 9, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Bausch Health Companies Inc. Common Stock
< Previous
1
2
3
4
5
6
7
Next >
Xifaxan(R) (rifaximin) Treatment Following Overt Hepatic Encephalopathy (OHE) Hospitalization Associated with Reduced Risk of 30-Day OHE Rehospitalization
May 06, 2025
Via
ACCESS Newswire
Bausch Health Announces First Quarter 2025 Results
April 30, 2025
Via
ACCESS Newswire
Bausch Health Announces Health Canada Clearance of Solta Medical's Thermage(R) FLX System
April 29, 2025
Via
ACCESS Newswire
Bausch Health Announces Launch of Solta Medical's Fraxel FTX(TM)
April 25, 2025
Via
ACCESS Newswire
Bausch Health Announces Filing of Supplement to Proxy Statement
April 22, 2025
Via
ACCESS Newswire
U.S. District Court Grants Summary Judgment in Favor of FDA, Salix, and Teva, and Against Norwich
April 17, 2025
Via
ACCESS Newswire
Bausch Health Announces Fourth Quarter and Full-Year 2024 Results
February 19, 2025
Via
ACCESS Newswire
Bausch Health Announces 2025 Salix Gastrointestinal Health Scholars Program
February 10, 2025
Via
ACCESS Newswire
Bausch Health Announces Adoption of Shareholder Rights Plan
April 14, 2025
Via
ACCESS Newswire
Bausch Health Announces Ortho Dermatologics 2025 ASPIRE HIGHER Scholarship Program
April 10, 2025
Via
ACCESS Newswire
Patient Voices Highlight the Realities of Living with Irritable Bowel Syndrome During IBS Awareness Month
April 02, 2025
Via
ACCESS Newswire
Bausch Health to Announce First Quarter Results on April 30
March 27, 2025
Via
ACCESS Newswire
Bausch Health Announces Pricing of Upsized Private Offering of Senior Secured Notes
March 25, 2025
Via
ACCESS Newswire
Bausch Health Announces Third Quarter 2024 Results
October 30, 2024
Via
ACCESSWIRE
Bausch Health Announces Conditional Redemption of Senior Notes
March 21, 2025
Via
ACCESS Newswire
Bausch Health Announces Launch of Syndication of New Senior Secured Credit Facilities
March 19, 2025
Via
ACCESS Newswire
Bausch Health Announces Launch of Private Offering of Senior Secured Notes and Conditional Redemption of Senior Notes
March 19, 2025
Via
ACCESS Newswire
Bausch Health Announces Next Steps in Financing Initiative with J.P. Morgan
March 14, 2025
Via
ACCESS Newswire
Bausch Health to Participate in the J.P. Morgan Global Leveraged Finance Conference
February 14, 2025
Via
ACCESS Newswire
Bausch Health Provides Update on Strategic Alternatives
February 06, 2025
Via
ACCESS Newswire
Bausch Health to Announce Fourth Quarter and Full Year 2024 Results on February 19, 2025
January 23, 2025
Via
ACCESS Newswire
Bausch Health Statement on Selection of XIFAXAN(R) (rifaximin) for Inflation Reduction Act's Medicare Negotiation Program
January 17, 2025
Via
ACCESS Newswire
Bausch Health Responds to Rumors of a Potential Sale of Bausch + Lomb
December 12, 2024
Via
ACCESSWIRE
Bausch Health and Salix in Collaboration with Health Organizations Recognize the Second Annual Opioid-Induced Constipation (OIC) Awareness Day
December 05, 2024
Via
ACCESSWIRE
Bausch Health Appoints New Chief Medical Officer and Head of R&D
December 02, 2024
Via
ACCESSWIRE
Bausch Health and Salix to Present at the American Association for the Study of Liver Disease (AASLD) the RED-C Phase 3 Study Design for a New Investigational Product Designed to Address Serious Complications of Cirrhosis
November 18, 2024
Via
ACCESSWIRE
PrCABTREOTM (clindamycin phosphate, adapalene and benzoyl peroxide gel) Treatment for Acne Vulgaris Receives Positive Reimbursement Recommendations from Canada's Drug Agency and Quebec's INESSS
November 18, 2024
Via
ACCESSWIRE
ACG Presidential Plenary to Highlight Analysis of Xifaxan(R) (rifaximin) Risk Reduction of Overt Hepatic Encephalopathy (OHE) Recurrence
October 27, 2024
Via
ACCESSWIRE
Bausch Health to Announce Third Quarter 2024 Results on October 30, 2024
October 09, 2024
Via
ACCESSWIRE
Bausch Health and Salix Survey Highlights Urgent Need for Improved Understanding of Liver Disease Across Healthcare Provider Disciplines as Prevalence of Cirrhosis Rises
October 08, 2024
Via
ACCESSWIRE
< Previous
1
2
3
4
5
6
7
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.